| Literature DB >> 34885821 |
Dan Zhao1, Meigeng Hu1, Guoxu Ma1, Xudong Xu1.
Abstract
Five new compounds called Pestalotis A-E (1-5), comprising three monoterpene-lactone compounds (1-3), one tetrahydrobenzofuran derivative (4), and one sesquiterpene (5), were isolated from the EtOAc extract of Pestalotiopsis sp. The structures of the new compounds were elucidated by analysis of their NMR, HRMS, and ECD spectra, and the absolute configurations were established through the comparison of experimental and calculated ECD spectra. All compounds were tested for antitumor activity against SW-480, LoVo, HuH-7, and MCF-7. The results showed that compounds 2 and 4 exhibited potent antitumor activity against SW-480, LoVo, and HuH-7 cell lines. Furthermore, compound 4 was assessed against HuH-7, and the results indicated that the rate of apoptosis was dose-dependent.Entities:
Keywords: HuH-7 cell lines; Ligusticum chuanxiong; Pestalotiopsis; cytotoxic activities; lung cancer; terpenes
Mesh:
Substances:
Year: 2021 PMID: 34885821 PMCID: PMC8672272 DOI: 10.3390/molecules26237229
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structures of compounds 1–5.
1H (600 MHz) and 13C-NMR (150 MHz) assignments of 1–3 (DMSO-d6).
| No. | 1 | 2 | 3 | |||
|---|---|---|---|---|---|---|
|
|
|
| ||||
| 2 | 174.0 | 174.0 | 177.3 | |||
| 3 | 120.1 | 120.1 | 40.9 | 2.11, m | ||
| 4 | 20.9 | 2.63, m | 20.9 | 2.63, m | 23.7 | 1.38, m |
| 2.45, m | ||||||
| 5 | 36.9 | 1.87, m | 36.8 | 2.26, m | 33.9 | 1.60, m |
| 1.54, m | 1.33, m | |||||
| 6 | 71.0 | 71.8 | 69.5 | |||
| 7 | 78.8 | 4.51, d, 9.6 | 79.5 | 4.50, d, 9.6 | 71.6 | 3.26, d, 3.6 |
| 8 | 80.7 | 4.97, d, 9.6 | 80.7 | 4.96, d, 9.6 | 71.9 | 4.96, d, 3.6 |
| 9 | 160.0 | 160.0 | 36.9 | 1.90, m | ||
| 10 | 8.3 | 1.74, s | 8.3 | 1.73, s | 15.3 | 0.97, d, 6.6 |
| 11 | 25.2 | 1.03, s | 24.3 | 1.05, s | 25.1 | 1.10, s |
| 1′ | 165.0 | 171.7 | 171.5 | |||
| 2′ | 115.1 | 5.81, s | 42.7 | 2.33, m | 42.9 | 2.25, m |
| 3′ | 158.5 | 25.3 | 2.08, m | 24.8 | 1.27, m | |
| 4′ | 20.1 | 2.14, s | 22.2 | 0.95, d, 6.6 | 22.1 | 0.91, m |
| 5′ | 27.0 | 1.93, s | 22.1 | 0.94, d, 6.6 | 22.1 | 0.91, m |
Figure 21H-1H COSY () and HMBC () correlations of compounds 1, 4 and 5.
Figure 3Key NOESY correlations of compounds 1 and 5.
1H (600 MHz) and 13C-NMR (150 MHz) assignments of 4 (DMSO-d6) and 5 (CD3OD).
| No. | 4 | 5 | ||
|---|---|---|---|---|
|
|
| |||
| 1 | 71.8 | |||
| 2 | 147.6 | 34.7 | 1.69, m | |
| 1.45, m | ||||
| 3 | 126.4 | 23.1 | 1.54, m | |
| 1.34, m | ||||
| 4 | 17.6 | 2.51, m | 40.1 | 1.84, m |
| 2.30, m | ||||
| 5 | 32.8 | 1.84, m | 151.2 | 7.01, d, 6.0 |
| 1.59, m | ||||
| 6 | 70.4 | 136.7 | ||
| 7 | 68.6 | 4.22, s | 202.6 | |
| 8 | 154.8 | 36.4 | 2.63, m | |
| 9 | 121.6 | 47.1 | 2.22, m | |
| 10 | 190.4 | 38.6 | 2.49, m | |
| 11 | 47.1 | 2.70, dd, 1.8, 7.2 | 33.7 | 2.12, m |
| 12 | 24.1 | 2.03, m | 69.4 | 2.41, m |
| 13 | 22.5 | 0.92, d, 2.4 | 11.1 | 0.99, d, 7.2 |
| 14 | 22.4 | 0.91, d, 2.4 | 16.2 | 1.77, s |
| 15 | 56.9 | 5.28, d, 13.2 | 27.6 | 1.30, s |
| 5.22, d, 13.2 | ||||
| 16 | 170.1 | 173.1 | ||
| 17 | 20.4 | 2.03, s | 21.0 | 2.01, s |
| 18 | 24.9 | 1.13, s | ||
In vitro antitumor activity of compounds.
| Compounds | IC50 (μM) | |||
|---|---|---|---|---|
| SW480 | LoVo | HuH-7 | McF-7 | |
| 1 | 14.3 ± 2.1 a | 13.8 ± 1.3 | 19.1 ± 4.8 | 31.5 ± 3.4 |
| 2 | 23.4 ± 2.0 | 37.0 ± 3.2 | 43.6 ± 1.2 | 37.2 ± 1.5 |
| 3 | 25.6 ± 2.1 | 37.2 ± 1.6 | 33.3 ± 1.8 | >100 |
| 4 | 15.0 ± 1.7 | 17.2 ± 1.8 | 9.3 ± 2.0 | 15.5 ± 1.4 |
| 5 | 32.3 ± 2.8 | 28.3 ± 2.0 | 20.1 ± 1.6 | >100 |
| 5-FU b | 1.2 ± 0.1 | 1.1 ± 0.1 | 1.3 ± 0.1 | 0.8 ± 0.1 |
a The values presented are the means ± SD of triplicate experiments. b Positive control substance.
Figure 4Annexin V PE/7-ADD stained apoptotic cells induced by compound 4 in HuH-7 cells. All data shown represent the means ± S.D. of 3 independent experiments. ∗ p < 0.05.